Gainesville, FL, United States of America

Yuansha Chen



 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuansha Chen: Innovator in Protein Export Systems

Introduction

Yuansha Chen is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of protein export systems. His innovative work focuses on enhancing the efficiency of recombinant protein production.

Latest Patents

Yuansha Chen holds a patent for a groundbreaking invention titled "Non-hemolytic ClyA for excretion of proteins." This patent describes a protein export system that utilizes non-hemolytic variants of HlyE family member proteins. The system is designed to efficiently produce recombinant proteins from host cells. In a preferred embodiment, the protein export system leverages the protein export machinery that is endogenous to the host bacterium into which the system vector is introduced. This innovation has the potential to streamline protein production processes in various biotechnological applications.

Career Highlights

Yuansha Chen is affiliated with the University System of Maryland, where he continues to advance research in protein export technologies. His work has garnered attention for its practical applications in the biotechnology industry. With a focus on improving protein production methods, Chen's contributions are paving the way for more efficient bioprocessing techniques.

Collaborations

Yuansha Chen collaborates with James Eugene Galen, further enhancing the research and development efforts in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving scientific breakthroughs.

Conclusion

In summary, Yuansha Chen is a prominent inventor whose work in protein export systems is making a significant impact in biotechnology. His patent for non-hemolytic ClyA showcases his innovative approach to enhancing recombinant protein production.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…